LFR-260 vs Traditional Phoropter in Visual Acuity Testing
An Evaluation of the LFR-260 Against a Traditional Phoropter in Visual Acuity Testing
1 other identifier
interventional
112
1 country
2
Brief Summary
The purpose of this study is to establish if LFR-260 (investigational device) is not inferior in effectiveness to a traditional phoropter (control device) when applied in visual acuity test in subjects undergoing a full routine eye examination. LFR-260 proposes to provide information of the visual capabilities of the patient. The test will be provided and supervised by a qualified eye care provider. The informed consent, screening, randomization (into the order of visual test device used), (visual) device testing (to include precision testing, remote and offsite testing) will all occur at a single visit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 9, 2022
CompletedFirst Posted
Study publicly available on registry
February 28, 2022
CompletedStudy Start
First participant enrolled
June 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2023
CompletedResults Posted
Study results publicly available
September 25, 2024
CompletedSeptember 25, 2024
August 1, 2024
7 months
February 9, 2022
June 25, 2024
August 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Effectiveness of LFR260 on Visual Acuity Test
Agreement of LFR-260 (investigational device) to traditional phoropter (comparator device) when applied in visual acuity test (eye chart test) in subjects undergoing a full routine eye examination. Agreement will be determined by demonstrating that the LFR-260 is within 0.5D (+/-) in measuring sphere and cylinder results and within 10 degrees for axis results among subjects with low astigmatism and within 5 degrees among subjects with moderate to high astigmatism from the traditional phoropter.
Day 0
Precision of LFR260 in Repeated Testing
Precision testing will also be conducted to confirm repeatability and reproducibility of the LFR-260.
Day 0
Secondary Outcomes (2)
Patient Satisfaction Survey
Day 0
Provider Satisfaction Survey
Day 0
Study Arms (2)
Group 1: LFR-260 first, then traditional phoropter
EXPERIMENTALThe LFR-260 was administered first in this group, followed by the traditional phoropter. The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams. The traditional phoropter is intended to be used for distance vision testing in any environment.
Group II: Traditional Phoropter first, then LFR-260
ACTIVE COMPARATORThe traditional phoropter was administered first in this group, followed by the traditional phoropter. The traditional phoropter is intended to be used for distance vision testing in any environment. The LFR-260 is a portable digital refractor which allows for determination of refractive error as well as for fully remote refractions during eye exams.
Interventions
Portable unit to evaluate visual refractive state of the patient
Standard unit for evaluating visual refractive state of the patient
Eligibility Criteria
You may qualify if:
- The participant or legal guardian is willing and able to understand, sign and date the Ethics committee approved study specific Informed Consent Form.
- The participant is a male or female between the ages of 12 and 65 (inclusive).
- The participant has no more than mild to moderate far-sightedness, near-sightedness, astigmatism or anisometropia.
- The participant is free of ocular and systemic abnormalities that might affect visual functions.
You may not qualify if:
- The participant has diabetes mellitus (Type 1 or 2).
- The participant has an autoimmune condition.
- The participant is pregnant (self-reported).
- The participant has an active corneal or conjunctival infection.
- The participant has an active corneal, conjunctival, or intraocular inflammation (i.e. - uveitis).
- The participant has diabetic retinopathy.
- The participant has glaucoma or ocular hypertension.
- The participant has macular degeneration.
- The participant has had a previous ocular surgery.
- The participant has ocular and systemic diseases or abnormalities that might affect visual functions.
- The participant has a history of amblyopia, strabismus, or any other binocular vision abnormality.
- The participant has a history of AMD (age macular degeneration).
- The participant is a prisoner, a transient or has been treated for alcohol and/or drug abuse in an inpatient substance abuse program within 6 months prior to proposed study enrolment.
- The participant will not be able to complete questionnaires.
- The participant is currently in an investigational study for a similar purpose.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
MCPHS
Worcester, Massachusetts, 01608, United States
Gold Coast Optometric Vision
Oyster Bay, New York, 11771, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Raul Mihali
- Organization
- Evolution Optiks
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2022
First Posted
February 28, 2022
Study Start
June 7, 2022
Primary Completion
January 6, 2023
Study Completion
January 6, 2023
Last Updated
September 25, 2024
Results First Posted
September 25, 2024
Record last verified: 2024-08